Research Topics
Species | Michael DiamondSummaryAffiliation: Washington University School of Medicine Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The broad-spectrum antiviral functions of IFIT and IFITM proteinsMichael S Diamond
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA
Nat Rev Immunol 13:46-57. 2013..This Review focuses on recent advances in identifying the unique mechanisms of action of IFIT and IFITM proteins, which explain their broad-spectrum activity against the replication, spread and pathogenesis of a range of human viruses...
Immune responses to West Nile virus infection in the central nervous systemHyelim Cho
Departments of Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
Viruses 4:3812-30. 2012..We will focus on defining the current state of knowledge of WNV entry, tropism, and host immune response in the CNS, all of which affect the balance between injury and successful clearance...
Cell-intrinsic innate immune control of West Nile virus infectionMichael S Diamond
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA
Trends Immunol 33:522-30. 2012....
Recent progress in West Nile virus diagnosis and vaccinationMarina De Filette
Laboratory of Gene Therapy, Faculty of Veterinary Sciences, Ghent University, Heidestraat 19, 9820 Merelbeke, Belgium
Vet Res 43:16. 2012..This review describes the molecular virology, epidemiology, pathogenesis, and highlights recent progress regarding diagnosis and vaccination against WNV infections...
A tetravalent dengue nanoparticle stimulates antibody production in miceElisângela F Silva
Institute of Biomedical Science, Federal University of Alfenas, Minas Gerais, Brazil
J Nanobiotechnology 10:13. 2012..Currently, there are no licensed vaccines or antiviral drugs to prevent or treat dengue infections. Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines...
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in miceMatthew D Dunn
Center for Vaccine Research, University of Pittsburgh, 9047 Biomedical Science Tower 3, Pittsburgh, PA 15261, USA
Virol J 7:95. 2010..In general, mice vaccinated with P28-adjuvated vaccines produced higher IgG titers than mice vaccinated with non-adjuvanted vaccines...
Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNABrian J Geiss
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA
Virol J 2:53. 2005..Here, we examine the ability of exogenous small interfering RNAs (siRNAs) to block the replication of West Nile virus in human cells...
Mechanisms of evasion of the type I interferon antiviral response by flavivirusesMichael S Diamond
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Interferon Cytokine Res 29:521-30. 2009..This review will summarize our current understanding of how mammalian cells recognize flaviviruses to induce an inhibitory IFN response and the countermeasures this group of viruses has evolved to antagonize this response...
Development of effective therapies against West Nile virus infectionMichael S Diamond
Department of Medicine, Washington University School of Medicine, Box 8051, St Louis, MO 63110, USA
Expert Rev Anti Infect Ther 3:931-44. 2005..This review describes the epidemiology, clinical presentation and pathogenesis of West Nile virus infection, and highlights recent progress towards an effective therapy...
Progress on the development of therapeutics against West Nile virusMichael S Diamond
Departments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States
Antiviral Res 83:214-27. 2009..This review describes the current state of knowledge on epidemiology, clinical presentation, pathogenesis, and immunobiology of WNV infection, and highlights progress toward an effective therapy...
The structural immunology of antibody protection against West Nile virusMichael S Diamond
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA
Immunol Rev 225:212-25. 2008..In this review, we discuss the structural, molecular, and immunologic basis for antibody-mediated protection against WNV, and its implications for novel therapeutic or vaccine strategies...
B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virusMichael S Diamond
Department of Medicine, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
J Virol 77:2578-86. 2003..We conclude that antibodies and B cells play a critical early role in the defense against disseminated infection by WNV...
Ebola images emerge from the caveMichael S Diamond
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
Cell Host Microbe 4:87-9. 2008..Recently, the crystal structure of the Ebola virus glycoprotein in complex with a human neutralizing antibody was illuminated, providing a path from the shadows toward understanding cellular attachment, viral fusion, and immune evasion...
A critical role for induced IgM in the protection against West Nile virus infectionMichael S Diamond
Washington University School of Medicine, 660 S Euclid Ave, Box 8051, St Louis, MO 63110, USA
J Exp Med 198:1853-62. 2003..Thus, the induction of a specific, neutralizing IgM response early in the course of WNV infection limits viremia and dissemination into the central nervous system, and protects against lethal infection...
A genetic basis for human susceptibility to West Nile virusMichael S Diamond
Department of Medicine, Washington University School of Medicine, Box 8051, 660 S Euclid Avenue, St Louis, MO 63110, USA
Trends Microbiol 14:287-9. 2006..The study highlights a possible risk in targeting this receptor for the prevention and/or treatment of infectious diseases...
Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virusMichael S Diamond
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
Viral Immunol 16:259-78. 2003..These findings are analyzed in the context of recent approaches to vaccine development and immunotherapy against WNV...
Evasion of innate and adaptive immunity by flavivirusesMichael S Diamond
Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110, United States of America
Immunol Cell Biol 81:196-206. 2003..A more thorough understanding of these principles could lead to improved models for viral pathogenesis and to strategies for the development of novel antiviral agents...
The host immunologic response to West Nile encephalitis virusMichael S Diamond
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
Front Biosci 14:3024-34. 2009..This review will focus on the interactions between WNV and the protective and pathogenic host immune responses...
Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infectionStephane Daffis
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Virol 82:8465-75. 2008..In contrast, in these cells the IFN-beta response remained largely intact. Our data suggest that the early protective IFN-alpha response against WNV occurs through an IRF-7-dependent transcriptional signal...
Toll-like receptor 3 has a protective role against West Nile virus infectionStephane Daffis
Departments of Medicine, Molecular Microbiology, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Virol 82:10349-58. 2008..Taken together, our data suggest that TLR3 serves a protective role against WNV in part, by restricting replication in neurons...
Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanismsStephane Daffis
Department of Medicine, Washington University School of Medicine, St Louis Missouri, United States of America
PLoS Pathog 3:e106. 2007..Collectively, our data suggest that cell-specific IRF-3 responses protect against WNV infection through both IFN-dependent and -independent programs...
The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virusBimmi Shrestha
Department of Medicine, 660 S Euclid Avenue, Box 8051, Washington University School of Medicine, St Louis, MO 63110, United States
Vaccine 26:2020-33. 2008....
Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous systemBimmi Shrestha
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA
J Virol 82:8956-64. 2008..Our data are most consistent with a model in which interaction of TNF-alpha with TNF-R1 protects against WNV infection by regulating migration of protective inflammatory cells into the brain during acute infection...
Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient miceMichael J Engle
Departments of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA
J Virol 77:12941-9. 2003..Thus, passive transfer of immune antibody improves clinical outcome even after WNV has disseminated into the central nervous system...
Role of CD8+ T cells in control of West Nile virus infectionBimmi Shrestha
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Virol 78:8312-21. 2004..Collectively, our experiments suggest that, while specific antibody is responsible for terminating viremia, CD8(+) T cells have an important function in clearing infection from tissues and preventing viral persistence...
Protective immune responses against West Nile virus are primed by distinct complement activation pathwaysErin Mehlhop
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
J Exp Med 203:1371-81. 2006..Our results suggest that individual pathways of complement activation control WNV infection by priming adaptive immune responses through distinct mechanisms...
Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signalingWhitney E Purtha
Departments of Medicine, Molecular Microbiology and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA
J Virol 82:10964-74. 2008....
The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous systemKristy J Szretter
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Virol 84:12125-38. 2010..Our experiments suggest that MyD88 restricts WNV by inhibiting replication in subsets of cells and modulating expression of chemokines that regulate immune cell migration into the central nervous system...
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survivalMelanie A Samuel
Department of Molecular Microbiology, Washington University School of Medicine, Campus Box 8051, 660 S Euclid Ave, St Louis, MO 63110, USA
J Virol 79:13350-61. 2005..Collectively, our data suggest that IFN-alpha/beta controls WNV infection by restricting tropism and viral burden and by preventing death of infected neurons...
Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cellsKyung Min Chung
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Virol 81:9551-5. 2007..These findings may be relevant for generating novel therapeutic MAbs or vaccines against flaviviruses that target the NS1 protein...
CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitisElizabeth Sitati
Department of Molecular Microbiology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
J Virol 81:9801-11. 2007..Beside its role in maturation of antibody responses, our experiments suggest a novel function of CD40-CD40L interactions: to facilitate T-cell migration across the blood-brain barrier to control WNV infection...
Complement activation is required for induction of a protective antibody response against West Nile virus infectionErin Mehlhop
Department of Medicine, Molecular Microbiology, and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, St Louis, MO 63110, USA
J Virol 79:7466-77. 2005..Overall, these results suggest that complement controls WNV infection, in part through its ability to induce a protective antibody response...
Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific mannerErin Mehlhop
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
Cell Host Microbe 2:417-26. 2007..IgG subclasses that avidly bind C1q induced minimal ADE in the presence of C1q. These findings add a layer of complexity for the analysis of humoral immunity and flavivirus infection...
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunityKai Hildner
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
Science 322:1097-100. 2008..Importantly, rejection of highly immunogenic syngeneic tumors was impaired in Batf3-/- mice. These results suggest an important role for CD8alpha+ dendritic cells and cross-presentation in responses to viruses and in tumor rejection...
Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment stepMatthew R Vogt
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Virol 83:6494-507. 2009..CR4348 and CR4354 human MAbs neutralize infection at a postattachment step in the viral life cycle, likely by inhibiting acid-induced fusion within the endosome...
Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitisMelanie A Samuel
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S Euclid Avenue, St Louis, MO 63110, USA
J Virol 81:2614-23. 2007..These studies establish that caspase 3-dependent apoptosis contributes to the pathogenesis of lethal WNV encephalitis and suggest possible novel therapeutic targets to restrict CNS injury...
CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous systemElizabeth M Sitati
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S Euclid Ave, St Louis, MO 63110, USA
J Virol 80:12060-9. 2006..Our experiments suggest that the dominant protective role of CD4(+) T cells during primary WNV infection is to provide help for antibody responses and sustain WNV-specific CD8(+) T-cell responses in the CNS that enable viral clearance...
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusTheodore Oliphant
Department of Molecular Microbiology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, Missouri 63110, USA
Nat Med 11:522-30. 2005..In postexposure therapeutic trials in mice, a single dose of humanized E16 protected mice against WNV-induced mortality, and may therefore be a viable treatment option against WNV infection in humans...
Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7Stephane Daffis
Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America
PLoS Pathog 5:e1000607. 2009....
Structural basis of West Nile virus neutralization by a therapeutic antibodyGrant E Nybakken
Department of Pathology, Washington University School of Medicine, St Louis, Missouri 63110, USA
Nature 437:764-9. 2005..Collectively, our results suggest that a vaccine strategy targeting the dominant DIII epitope may elicit safe and effective immune responses against flaviviral diseases...
Defining the levels of secreted non-structural protein NS1 after West Nile virus infection in cell culture and miceKyung Min Chung
Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
J Med Virol 80:547-56. 2008..Overall, the NS1-based capture ELISA is a sensitive readout of infection and could be an important tool for diagnosis or screening small molecule inhibitors of WNV infection...
PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neuronsMelanie A Samuel
Department of Molecular Microbiology, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
J Virol 80:7009-19. 2006..Our data suggest that PKR and RNase L contribute to IFN-mediated protection in a cell-restricted manner and control WNV infection in peripheral tissues and some neuronal subtypes...
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanismsKyung Min Chung
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S Euclid Avenue, St Louis, MO 63110, USA
J Virol 80:1340-51. 2006..Overall, our data suggest that distinct regions of NS1 can elicit protective humoral immunity against WNV through different mechanisms...
Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitisRobyn S Klein
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Virol 79:11457-66. 2005....
Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectinAnja Fuchs
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
Cell Host Microbe 8:186-95. 2010..Our studies show that MBL recognizes terminal mannose-containing carbohydrates on flaviviruses, resulting in neutralization and efficient clearance in vivo...
Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2Soila Sukupolvi-Petty
Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, St Louis, MO 63110, USA
J Virol 84:9227-39. 2010..Overall, these studies define the structural and functional complexity of antibodies against DENV-2 with protective potential...
Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virusRobyn S Klein
Department of Internal Medicine, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
Trends Mol Med 14:286-94. 2008..Here, we present our current understanding of the innate and adaptive immune responses that limit dissemination to the CNS from WNV infection and the antiviral immune responses within the CNS that intervene when they fail...
Induction of epitope-specific neutralizing antibodies against West Nile virusTheodore Oliphant
Departments of Medicine, Molecular Microbiology, and Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
J Virol 81:11828-39. 2007....
Herpesvirus latency confers symbiotic protection from bacterial infectionErik S Barton
Departments of Pathology and Immunology, Washington University Medical School, 660 South Euclid Avenue, St Louis, Missouri 63110, USA
Nature 447:326-9. 2007..Thus, whereas the immune evasion capabilities and lifelong persistence of herpesviruses are commonly viewed as solely pathogenic, our data suggest that latency is a symbiotic relationship with immune benefits for the host...
The molecular basis of antibody-mediated neutralization of West Nile virusTheodore Oliphant
Washington University School of Medicine, Department of Molecular Microbiology, Saint Louis, MO 63110, USA
Expert Opin Biol Ther 7:885-92. 2007..Antibodies that bind to this epitope are particularly inhibitory because they block infection at a post-attachment step and at concentrations that result in a low occupancy of the available sites on the virion...
Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopesSoila Sukupolvi Petty
Department of Medicine, Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA
J Virol 81:12816-26. 2007..Overall, our experiments define adjacent and structurally distinct epitopes on DIII of DENV-2 which elicit type-specific, subcomplex-specific, and cross-reactive antibodies with different neutralizing potentials...
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infectionSojung Kim
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
J Immunol 184:4423-30. 2010....
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infectionBimmi Shrestha
Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, St. Louis, MO 63110, USA
J Virol 80:5338-48. 2006..Collectively, our experiments suggest that the dominant protective role of IFN-gamma against WNV is antiviral in nature, occurs in peripheral lymphoid tissues, and prevents viral dissemination to the CNS...
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirusLeonid Gitlin
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St Louis, MO 63110, USA
Proc Natl Acad Sci U S A 103:8459-64. 2006..Moreover, mda-5-/- mice exhibited a selectively impaired antiviral response to encephalomyocarditis picornavirus, indicating functional specialization of mda-5 in vivo...
CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitisErin E McCandless
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
Proc Natl Acad Sci U S A 105:11270-5. 2008..The benefits of enhanced CD8(+) T cell infiltration suggest that pharmacologic targeting of CXCR4 may have therapeutic utility for the treatment of acute viral infections of the CNS...
Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virusErin Mehlhop
Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110, USA
Cell Host Microbe 6:381-91. 2009....
Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanismErin Mehlhop
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
Virology 393:11-5. 2009..Overall, these results enhance our mechanistic understanding of how complement controls flavivirus infections...
TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitisBo Zhang
Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO 63110, USA
J Neuroimmunol 224:28-38. 2010..These results suggest that neuronal TNF-alpha expression during WNV encephalitis may be an adaptive response to diminish CXCL10-induced death...
CD8+ T cells require perforin to clear West Nile virus from infected neuronsBimmi Shrestha
Departments of Medicine, Molecular Microbiology, Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, St Louis, MO 63110, USA
J Virol 80:119-29. 2006..Taken together, our data suggest that despite the risk of immunopathogenesis, CD8+ T cells use a perforin-dependent mechanism to clear WNV from infected neurons...
Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivoKevin Whitby
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St. Louis, MO 63110, USA
J Virol 79:8698-706. 2005..Overall, our data suggest that castanospermine has a strong antiviral effect on dengue virus infection and warrants further development as a possible treatment in humans...
Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope proteinTheodore Oliphant
Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, Saint Louis, MO 63110, USA
J Virol 80:12149-59. 2006..Nonetheless, DI and DII MAbs protect against WNV infection in mice, albeit with lower efficiency than DIII-specific neutralizing MAbs...
A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomesBruce S Thompson
Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA
PLoS Pathog 5:e1000453. 2009..Thus, a strongly neutralizing anti-WNV MAb with therapeutic potential is potently inhibitory because it blocks viral fusion and thereby promotes clearance by delivering virus to the lysosome for destruction...
Infection and injury of neurons by West Nile encephalitis virusBimmi Shrestha
Departments of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA
J Virol 77:13203-13. 2003....
Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous systemBimmi Shrestha
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA
J Virol 81:11749-57. 2007..Overall, our data suggest that CD8+ T cells also utilize FasL effector mechanisms to contain WNV infection in Fas-expressing neurons in the CNS...
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasionMelanie A Samuel
Division of Infectious Diseases, Department of Molecular Microbiology, Washington University School of Medicine, Campus Box 8051, 660 S. Euclid Ave, St. Louis, MO 63110, USA
J Virol 80:9349-60. 2006
Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virusStephane Daffis
Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Innate Immun 1:435-45. 2009....
Identification of novel small-molecule inhibitors of West Nile virus infectionAmine O Noueiry
Apath, LLC, St Louis, MO 63110, USA
J Virol 81:11992-2004. 2007..Overall, these compounds comprise a novel class of promising inhibitors for therapy against WNV and other flavivirus infections in humans...
The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesisKristy J Szretter
Departments of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
J Virol 83:9329-38. 2009....
Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitisWhitney E Purtha
Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
Eur J Immunol 37:1845-54. 2007..Based on this, we conclude that CTL responses against immundominant WNV epitopes confer protective immunity and thus should be targets for inclusion in new vaccines...
The interferon-inducible gene viperin restricts West Nile virus pathogenesisKristy J Szretter
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110, USA
J Virol 85:11557-66. 2011..Our experiments suggest that viperin restricts the infection of WNV in a tissue- and cell-type-specific manner and may be an important ISG for controlling viral infections that cause CNS disease...
Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanismsMatthew R Vogt
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA
J Virol 85:11567-80. 2011....
Beta interferon controls West Nile virus infection and pathogenesis in miceHelen M Lazear
Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA
J Virol 85:7186-94. 2011..Collectively, these results suggest that IFN-β controls WNV pathogenesis by restricting infection in key cell types and by modulating T cell regulatory networks...
Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment stepMichelle C Sabo
Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Ave, Box 8051, Saint Louis, MO 63110, USA
J Virol 85:7005-19. 2011..Collectively, these studies help to define the structural and functional complexity of antibodies against HCV E2 protein with neutralizing potential...
The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon responseStephane Daffis
Department of Medicine, Molecular Microbiology and Pathology and Immunology, Washington University School of Medicine, St Louis Missouri 63110, USA
J Virol 85:5664-8. 2011..Thus, WNV(KUN) is attenuated primarily through its enhanced restriction by type I interferon- and IRF-3-dependent mechanisms...
Pathogenesis of flavivirus encephalitisThomas J Chambers
Department of Molecular Microbiology and Immunology, St. Louis University Health Sciences Center, School of Medicine, St. Louis, Missouri 63104, USA
Adv Virus Res 60:273-342. 2003
The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infectionTheodore C Pierson
Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, MD 20892, USA
Cell Host Microbe 1:135-45. 2007..Thus, neutralization is best described by a model requiring "multiple hits" with the cumulative functional outcome determined by interplay between antibody affinity and epitope accessibility...
CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitisBo Zhang
Division of Infectious Diseases, Children s Hospital of Boston, Boston, MA, USA
J Immunol 180:2641-9. 2008..These results indicate that WNV differentially induces CXCL10 within neuronal populations and suggest a novel model for nonredundancy in chemokine-mediated inflammation among CNS compartments...
Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamstersJohn D Morrey
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322 4700, USA
J Infect Dis 194:1300-8. 2006..These experiments suggest that humanized MAbs with potent neutralizing activity are a possible treatment for human patients after WNV has infected neurons in the central nervous system...
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virusL Hannah Gould
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520, USA
J Virol 79:14606-13. 2005..These recombinant human scFvs are potential candidates for immunoprophylaxis and therapy of flavivirus infections...
Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster modelJohn D Morrey
Institute for Antiviral Research, Animal, Dairy, and Veterinary Sciences Department, Utah State University, 4700 Old Main Hill, Logan, UT 84322 4700, USA
Antimicrob Agents Chemother 51:2396-402. 2007..3 microg/ml or higher. Overall, these data suggest that in hamsters hE16 can ameliorate neurological disease after significant viral replication has occurred, although there is a time window that limits therapeutic efficacy...
Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralizationSteevenson Nelson
Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
PLoS Pathog 4:e1000060. 2008..Thus, in addition to a role in facilitating viral entry, changes in E protein arrangement associated with maturation modulate neutralization sensitivity and introduce an additional layer of complexity into humoral immunity against WNV...
A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infectionTheodore C Pierson
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Virology 346:53-65. 2006..WNV RVPs are capable of only a single round of infection, can be used under BSL-2 conditions, and offer a rapid and quantitative approach for detecting virus entry and its inhibition by neutralizing antibody...
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine developmentTheodore C Pierson
Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, 33 North Drive, Building 33, Room 1E19A 2, Bethesda, MD 20892, USA
Cell Host Microbe 4:229-38. 2008..These insights have identified factors that govern the potency of neutralizing antibodies and will inform the design and evaluation of novel vaccines...
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infectionTheodore C Pierson
Viral Pathogenesis Section, Laboratory of Viral Diseases, NIAID, NIH, Bethesda, MD 20892, USA
Expert Rev Mol Med 10:e12. 2008..How recent advances in this area have the potential to improve the development of safe and effective vaccines and immunotherapeutics is also addressed...
West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsJohn D Morrey
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322 4700, USA
J Neurovirol 14:152-63. 2008....
Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinaseSergey A Shiryaev
The Burnham Institute, La Jolla, CA 92037, USA
Biochem J 393:503-11. 2006..Overall, our findings represent a foundation for in-depth mechanistic and structural studies as well as for the design of novel and efficient inhibitors of WNV NS3...
Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteinsShee Mei Lok
Department of Biological Sciences, Purdue University, 915 West State Street, West Lafayette, Indiana 47907 2054, USA
Nat Struct Mol Biol 15:312-7. 2008..The changes in the structure of the viral surface are presumably responsible for inhibiting attachment to cells...
Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysisMelanie A Samuel
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA
Proc Natl Acad Sci U S A 104:17140-5. 2007..Moreover, antibody therapeutics directly inhibit transneuronal spread of WNV infection and prevent the development of paralysis in vivo...
Crystal structure of the West Nile virus envelope glycoproteinGrant E Nybakken
Department of Pathology and Immunology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Avenue, St Louis, MO 63110 1093, USA
J Virol 80:11467-74. 2006..We speculate that E proteins could pivot around the fusion loop-pocket junction, allowing virion conformational transitions while minimizing fusion loop exposure...
An infectious West Nile virus that expresses a GFP reporter geneTheodore C Pierson
Department of Microbiology, University of Pennsylvania, 225 Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA
Virology 334:28-40. 2005..We anticipate this DNA-based, infectious WNV reporter virus will allow novel approaches for the study of WNV infection and its inhibition both in vitro and in vivo...
West Nile virus: crossing the blood-brain barrierMichael S Diamond
Nat Med 10:1294-5. 2004
Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulenceBrian C Keller
Department of Microbiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9048, USA
J Virol 80:9424-34. 2006..Consistent with this finding, the virulence of MAD78 was unmasked upon infection of mice lacking IFNAR. Thus, control of the innate host response and IFN actions is a key feature of WNV pathogenesis and replication fitness...
Research Grants
- Antibody Based Therapeuticcs for Chikungunya VirusMichael S Diamond; Fiscal Year: 2010..Overall, the generation of strongly protective humanized MAbs against CHIKV will foster the clinical development of immunotherapeutic agents against CHIKV infection. ..
- INTERFERON IN MODULATING DENGUE VIRUS INFECTIONMichael Diamond; Fiscal Year: 2002....
- Antibody-Based Protection Against Dengue VirusMichael S Diamond; Fiscal Year: 2010..In Specific Aim 4, we will develop epitope-based diagnostic assays and immunogens for DENV. Collectively, these studies may be of significant importance in ongoing and future DENV vaccine development programs. ..
- Antibody-Based Protection Against Dengue VirusMichael Diamond; Fiscal Year: 2007..In Specific Aim 4, we will develop epitope-based diagnostic assays and immunogens for DENV. Collectively, these studies may be of significant importance in ongoing and future DENV vaccine development programs. ..
- Monoclonal Antibody Therapy for West Nile VirusMichael Diamond; Fiscal Year: 2007..These studies are an essential first step in the generation of humanized mAbs that have utility as therapeutic agents against WNV in humans. ..
- Development of Novel Antiviral Agents VS West Nile VirusMichael Diamond; Fiscal Year: 2006....
